4th Quarter - Termination Amendment

CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. for NAVIGENICS, INC.

Firm
Client
Income
$10,000
Expenses
—
Terminated
Nov 30, 2011

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Termination Jan 18, 2012 $10,000 Replaced
4th Quarter - Termination Amendment (this page) Dec 31, 2012 $10,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Oversight and regulation of genetic testing Direct to consumer genetic testing

LobbyistCovered position, as disclosed
JENNIFER RACHEL LEIB Policy Fellow, NIH/NHGRI Office of the Director

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Consumer Issues/Safety/Products CSP

Direct to consumer genetic testing.

LobbyistCovered position, as disclosed
JENNIFER RACHEL LEIB Policy Fellow, NIH/NHGRI Office of the Director

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Medical/Disease Research/Clinical Labs MED

Oversight and regulation of genetic testing. Direct to consumer genetic testing.

LobbyistCovered position, as disclosed
JENNIFER RACHEL LEIB Policy Fellow, NIH/NHGRI Office of the Director

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.